Akoya BioSciences (AKYA) Peer Comparison

$1.29

$0.00 (0.00%)

As on 16-Jul-2025 09:30EDT

Market cap

$64 Mln

Revenue (TTM)

$80 Mln

P/E Ratio

--

P/B Ratio

6.5

Div. Yield

0 %

Edit

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Market cap ($ Mln)	64	106
Revenue ($ Mln)	80	20
Net Profit ($ Mln)	-47.53	-5.23
Net Margin (%)	-59.45	-26.77
RoE (%)	--	-17.38
Price to Earnings	--	--
Price-To-Book	6.45	3.45

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Operating Revenue	79.96	19.53
Cost of Revenue	30.59	2.82
Gross Profit	47.88	16.64
Operating Expenses	87.69	22.55
Operating Profit (EBIT)	-38.56	-5.96
Other Income	0.00	0.00
Profit before Tax	-47.40	-5.13
Provision for Tax	0.04	0.17
Profit after Tax (Net Income)	-47.53	-5.23
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Shareholder's Funds	-5.89	30.79
Minority Interest	0.00	0.00
Non-Current Liabilities	10.46	0.99
Current Liabilities	108.08	7.69
Total Liabilities	125.01	37.54

Assets ($ Mln)

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Non-Current Assets	46.44	11.35
Current Assets	66.21	28.12
Total Assets	125.01	37.54
Total Debt*	83.72	0.31
Net Current Assets	-41.87	20.43

Cashflow ($ Mln)

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Cash From Operating Activities	-44.10	-3.95
Cash Flow from Investing Activities	-24.05	-0.52
Cash from Financing Activities	-3.21	0.00
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Akoya BioSciences (AKYA)	icad inc (ICAD)
ROCE (%)	-47.89	-17.85
ROE (%)	-180.44	-17.38
ROA (%)	-23.26	-11.15
EBIT Margin (%)	-37.32	-27.74
Net Margin (%)	-59.45	-26.77
Cash Profit Margin (%)	0.00	0.00

Growth Ratios

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Revenue Growth (%)	-14.55	-0.53
EBIT Growth (%)	49.09	-7.71
Net Profit Growth (%)	30.10	-75.17
EPS Growth (%)	34.87	-68.32
Book Value Growth (%)	-117.82	-6.42

Valuation Ratios

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Price / Earnings	-2.05	-8.59
Price / Book Value	14.94	1.68
Dividend Yield (%)	--	--
EV/EBITDA	-4.38	-6.43
Market Cap ($ Cr)	--	--

Solvency Ratios

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	-13.53	0.01
Current Ratio	0.61	3.66
Quick Ratio	0.40	3.57
Interest Coverage	-3.60	-212.92

Operating Efficiency Ratios

	Akoya BioSciences (AKYA)	icad inc (ICAD)
Debtors to sales (%)	14.68	33.94
Asset Turnover	0.39	0.42
Receivable days	68.81	126.66
Inventory Days	228.04	102.77
Payable days	110.97	111.98
Cash Conversion Cycle	185.88	117.44

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly